Misfolded proteins in Alzheimer's disease and type II diabetes
Citations Over TimeTop 1% of 2011 papers
Abstract
This tutorial review presents descriptions of two amyloidogenic proteins, amyloid-β (Aβ) peptides and islet amyloid polypeptide (IAPP), whose misfolding propensities are implicated in Alzheimer's disease (AD) and type II diabetes, respectively. Protein misfolding diseases share similarities, as well as some unique protein-specific traits, that could contribute to the initiation and/or development of their associated conditions. Aβ and IAPP are representative amyloidoses and are used to highlight some of the primary considerations for studying misfolded proteins associated with human diseases in this review. Among these factors, their physiological formation, aggregation, interactions with metal ions and other protein partners, and toxicity are presented. Small molecules that target and modulate the metal-Aβ interaction and neurotoxicity are included to illustrate one of the current approaches for uncovering the complexities of protein misfolding at the molecular level.
Related Papers
- → Fundamentals of Enzymology(1983)164 cited
- → Contrasting Disease and Nondisease Protein Aggregation by Molecular Simulation(2008)36 cited
- → Understanding protein folding from globular to amyloid state(2013)20 cited
- Bistability of protein aggregation as a function of molecular chaperone concentration(2005)
- [Unprogrammed protein folding--the formation of amyloid fibrils].(2015)